The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The case takes aim at the major pharmacy benefit managers, agency officials said, claiming that they favored more expensive ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...

The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes ...